Scott E Delacroix - Louisiana State University Health Sciences Center New Orleans

Camille Azar Callaway, Brett Christopher Haaga, Mary Beth Westerman,Scott Delacroix, Jaya Mishra,Jessie Gills, Carrie Marquette, Siddhartha Padmanabha, Paul Monsour

Urologic Oncology Seminars and Original Investigationsno. 3 (2025): 44

Cited0Views0Bibtex

Supplementary Figure S3 from A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or Without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer

crossref（2025）

Cited0Views0Bibtex

Supplementary Figure S5 from A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or Without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer

crossref（2025）

Cited0Views0Bibtex

Supplementary Table S1 from A Phase II Open-Label, Randomized Clinical Trial of Atezolizumab with or Without Human Recombinant IL-7 (CYT107) in Advanced Urothelial Cancer

crossref（2025）

Cited0Views0Bibtex

Perioperative Nivolumab Versus Observation in Patients with Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER ECOG-ACRIN EA8143): an Open-Label, Randomised, Phase 3 Study

LANCET ONCOLOGYno. 8 (2024): 1038-1052

Cited0Views0WOSBibtex

Giants in Urology: Dr. Christopher G. Wood (22 November 1963 to 3 November 2021)

Philippe E. Spiess,Scott E. Delacroix,Brian F. Chapin,Vitaly Margulis,E. Jason Abel,José A. Karam

Société Internationale d’Urologie Journalno. 1 (2024): 4-6

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn